Express Press Release Distribution

Accounting
Advertising
Aerospace
Agriculture
Apparel & Fashion
Automotive
Biotech
Chemicals
Computers
Construction
Consumer Services
Defense
Education
Electronics
Energy
Entertainment
Environment
Financial
Food & Beverage
Government
Healthcare
Human Resources
Industrial
International Trade
Internet & Online
Law
Management
Marketing
Media
Non Profit
Pharmaceuticals
Real Estate
Retail
Semiconductors
Small Business
Software
Sports
Telecommunications
Transportation / Logistics
Travel

EPR Archived News

Archived News 2012
~ April
~ March
~ February
~ January

Archived News 2011
~ December
~ November
~ October
~ September
~ August
~ July
~ June
~ May
~ April
~ March
~ February
~ January

Archived News 2010
Archived News 2009
Archived News 2008
Archived News 2007
Archived News 2006
Archived News 2005
Archived News 2004

 

Roche Diagnostics to Present New Data at GTCbio`s Rediscovering Biomarkers Conference (July 23-24, San Diego, CA)

Released on = May 8, 2007, 3:01 pm

Press Release Author = GTCbio

Industry = Pharmaceuticals

Press Release Summary = Biotech/Pharmaceutical conference (GTCbio\'s Rediscovering
Biomarkers: Detection, Development and Validation conference) features Roche
Diagnostics at San Diego event.

Press Release Body = Dr. Michael Tacke, Director of Proteomics at Roche Diagnostics
in Penzberg, Germany will present on “Chances and Hurdes in the Quest for New Cancer
Biomarkers Using Proteomic Technologies” at Rediscovering Biomarkers: Detection,
Development, and Validation Conference on July 23-24, 2007 in San Diego, CA.

In many diagnostic and therapeutic areas there is a high medical need for novel
biomarkers with improved sensitivity and specificity. One area of particular
interest is the early detection of cancer since for many tumors curative treatment
options are only available at early disease stages. Proteomics technologies are now
offering unique chances to identify new candidate markers. Before bringing a new
marker into the market three successive developmental phases have to be complemented
– a marker discovery phase, in which a variety of proteomics technologies can be
applied, a validation phase in which the diagnostic performance of candidate markers
has to be assessed in defined sample collectives of sufficient size and finally the
product development phase with the transfer of the marker to a robust test platform.
The hurdles that a potential candidate marker has to pass in each developmental
phase are considerable and will be addressed in this presentation.

The Rediscovering Biomarkers: Detection, Development, and Validation conference will
take place on July 23-24, 2007 at the San Diego Marriott La Jolla in La Jolla, CA.
Additional topics to be covered include Biomarker Application in Oncology; Tools for
Improving Measurement, Safety, and Validation; and Leveraging Upcoming Trends and
Technologies.

For more information including a detailed agenda, exhibitor opportunities and
registration information visit
http://www.gtcbio.com/conference/conferenceDetails.aspx?id

Web Site = http://www.gtcbio.com/conference/conferenceDetails.aspx?id

Contact Details = GTCbio
434 W Foothill Bl
Monrovia, CA 91016
626-256-6405
lily.chen@gtcbio.com

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •